Source: Clinical Trials Arena

AlgoTx: AlgoTx begins Phase II trial of neuropathy pain relief treatment

The company anticipates reporting preliminary data from the trial in early 2024. The post AlgoTx begins Phase II trial of neuropathy pain relief treatment appeared first on Clinical Trials Arena.

Read full article »
AlgoTx's Competitors | AlgoTx's News | AlgoTx's Financials
Stay up-to-date with the latest news on AlgoTx
Est. Annual Revenue
$5.0-25M
Est. Employees
1-25
Stephane Thiroloix's photo - President & CEO of AlgoTx

President & CEO

Stephane Thiroloix

CEO Approval Rating

90/100

Read more
Stay up-to-date with the latest news on AlgoTx